David A Kendrick

Title: David A Kendrick: Innovator in Fluorinated Compounds

Introduction

David A Kendrick is a notable inventor based in Illkirch Graffenstaden, France. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds that have potential applications in pharmaceuticals.

Latest Patents

Kendrick holds a patent for "Fluorinated diaminoalkyne derivatives." This innovative patent describes fluorinated diaminoalkyne derivatives that act as inhibitors of the ornithine decarboxylase enzyme. The compounds are characterized by a general formula where R represents C1-C4 alkyl, or preferably, hydrogen. This patent showcases Kendrick's expertise in creating compounds that could have important therapeutic implications.

Career Highlights

David A Kendrick is associated with Merrell Dow Pharmaceuticals, where he has been involved in research and development. His work at the company has allowed him to explore various chemical compounds and their potential uses in medicine. Kendrick's dedication to innovation in the pharmaceutical field is evident through his patent and ongoing research efforts.

Collaborations

Kendrick has collaborated with Michael Kolb, a fellow researcher, to advance their work in the field of chemistry. Their partnership has contributed to the development of new compounds and has fostered a collaborative environment for innovation.

Conclusion

David A Kendrick is a prominent inventor whose work on fluorinated diaminoalkyne derivatives highlights his contributions to the pharmaceutical industry. His patent reflects a commitment to advancing chemical research and developing new therapeutic options.